Skip to content
10-Q

Quarterly Report

INHIBRX BIOSCIENCES, INC. INBX

0002007919-25-000093

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 14.54M sh
Shares Diluted Q3 2025 · Sep 30, 2025 15.48M sh
Shares Diluted Q3 2025 · Sep 30, 2025 15.47M sh
Shares Diluted Q3 2025 · Sep 30, 2024 15.47M sh
Shares Diluted Q3 2025 · Sep 30, 2024 14.82M sh
Capex Q3 2025 · Sep 30, 2025 $31K
Capex Q3 2025 · Sep 30, 2024 $2.58M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$99.67M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$150.69M
Long Term Debt Q3 2025 · Sep 30, 2025 $99.92M
Long Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $153.09M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $152.6M
Stockholders Equity Q3 2025 · Sep 30, 2025 $36.83M
Stockholders Equity Q3 2025 · Jun 30, 2025 $68.56M
Stockholders Equity Q3 2025 · Mar 31, 2025 $94.44M
Stockholders Equity Q3 2025 · Dec 31, 2024 $133.58M
Stockholders Equity Q3 2025 · Sep 30, 2024 $178.47M
Stockholders Equity Q3 2025 · Jun 30, 2024 $219.37M
Stockholders Equity Q3 2025 · Mar 31, 2024 $11.57M
Stockholders Equity Q3 2025 · Dec 31, 2023 $43.5M
Current Liabilities Q3 2025 · Sep 30, 2025 $35.98M
Current Liabilities Q3 2025 · Dec 31, 2024 $40.73M
Total Liabilities Q3 2025 · Sep 30, 2025 $140.64M
Total Liabilities Q3 2025 · Dec 31, 2024 $47.18M
Current Assets Q3 2025 · Sep 30, 2025 $161.42M
Current Assets Q3 2025 · Dec 31, 2024 $160.4M
Total Assets Q3 2025 · Sep 30, 2025 $177.47M
Total Assets Q3 2025 · Dec 31, 2024 $180.77M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.28
Eps Diluted Q3 2025 · Sep 30, 2025 −$6.93
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.84
Eps Diluted Q3 2025 · Sep 30, 2024 $117.09
Eps Basic Q3 2025 · Sep 30, 2025 −$2.28
Eps Basic Q3 2025 · Sep 30, 2025 −$6.93
Eps Basic Q3 2025 · Sep 30, 2024 −$2.84
Eps Basic Q3 2025 · Sep 30, 2024 $119.04
Sga Expense Q3 2025 · Sep 30, 2025 $5.28M
Sga Expense Q3 2025 · Sep 30, 2025 $17.72M
Sga Expense Q3 2025 · Sep 30, 2024 $7.9M
Sga Expense Q3 2025 · Sep 30, 2024 $111.24M
Rd Expense Q3 2025 · Sep 30, 2025 $28.54M
Rd Expense Q3 2025 · Sep 30, 2025 $87.68M
Rd Expense Q3 2025 · Sep 30, 2024 $38.89M
Rd Expense Q3 2025 · Sep 30, 2024 $170.38M
Net Income Q3 2025 · Sep 30, 2025 −$35.26M
Net Income Q3 2025 · Sep 30, 2025 −$107.22M
Net Income Q3 2025 · Jun 30, 2025 −$28.65M
Net Income Q3 2025 · Mar 31, 2025 −$43.31M
Net Income Q3 2025 · Sep 30, 2024 −$43.86M
Net Income Q3 2025 · Sep 30, 2024 $1.74B
Net Income Q3 2025 · Jun 30, 2024 $1.86B
Net Income Q3 2025 · Mar 31, 2024 −$78.71M
Operating Income Q3 2025 · Sep 30, 2025 −$33.81M
Operating Income Q3 2025 · Sep 30, 2025 −$104.1M
Operating Income Q3 2025 · Sep 30, 2024 −$46.8M
Operating Income Q3 2025 · Sep 30, 2024 −$281.52M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $1.3M
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $100K